524314 — Gujarat Terce Laboratories Balance Sheet
0.000.00%
Last trade - 00:00- IN₹412.64m
- IN₹404.15m
- IN₹501.95m
- 54
- 48
- 32
- 40
Annual balance sheet for Gujarat Terce Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 12.9 | 15.1 | 20.3 | 0.901 | 17.9 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 53.1 | 57 | 82.5 | 58.7 | 52.9 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 120 | 155 | 160 | 112 | 120 |
| Net Property, Plant And Equipment | 24.5 | 42.9 | 39.9 | 36.9 | 36.5 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 218 | 274 | 285 | 233 | 228 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 116 | 132 | 166 | 121 | 126 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 141 | 189 | 217 | 162 | 164 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 76.6 | 85.3 | 68.6 | 71.1 | 64.8 |
| Total Liabilities & Shareholders' Equity | 218 | 274 | 285 | 233 | 228 |
| Total Common Shares Outstanding |